Off-the-shelf vaccine shows promise in preventing cancers returning, study finds

In the study 25 patients were given a vaccine called ELI-002 2P, which works by training the body’s T-cells to recognise and kill cancer cells. Photograph: Nick Potts/PA

An off-the-shelf vaccine has shown promise in preventing the return of pancreatic and colorectal cancer, researchers have revealed.

Cancer vaccines have been the subject of promising research in recent years. The NHS in England has been trialling various jabs in patients through the Cancer Vaccine Launch Pad (CVLP).